Transduction of CpG DNA-stimulated primary human B cells with bicistronic lentivectors

被引:19
作者
Kvell, K
Nguyen, TH
Salmon, P
Glauser, F
Werner-Favre, C
Barnet, M
Schneider, P
Trono, D
Zubler, RH [1 ]
机构
[1] Univ Hosp Geneva, Div Hematol, Dept Internal Med, CH-1211 Geneva, Switzerland
[2] Univ Hosp Geneva, Dept Genet & Microbiol, CH-1211 Geneva, Switzerland
[3] Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland
关键词
HIV-1-derived lentivectors; bicistronic vectors; human primary B lymphocytes; CpG DNA; viral FLIP;
D O I
10.1016/j.ymthe.2005.05.010
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Recently, using HIV-1-derived lentivectors, we obtained efficient transduction of primary human B lymphocytes cocultured with murine EL-4 135 thymoma cells, but not of isolated B cells activated by CD40 ligation. Coculture with a cell line is problematic for gene therapy applications or study of gene functions. We have now found that transduction of B cells in a system using CpG DNA was comparable to that in the EL-4 B5 system. A monocistronic vector with a CMV promoter gave 32 +/- 4.7% green fluorescent protein (GFP)(+) cells. A bicistronic vector, encoding IL-4 and GFP in the first and second cistrons, respectively, gave 14.2 +/- 2.1% GFP(+) cells and IL-4 secretion of 1.3 +/- 0.2 ng/10(5) B cells/24 h. This was similar to results obtained in CD34(+) cells using the elongation factor-lot promoter. Activated memory and naive B cells were transducible. After transduction with a bicistronic vector encoding a viral FLIP molecule, vFLIP was detectable by FACS or Western blot in GFP(+), but not in GFP(-), B cells, and 57% of sorted GFP(+) B cells were protected against Fas ligand-induced cell death. This system should be useful for gene function research in primary B cells and development of gene therapies.
引用
收藏
页码:892 / 899
页数:8
相关论文
共 31 条
[1]  
Ballantyne J, 1998, J IMMUNOL, V161, P1336
[2]   An engineered EBV vector expressing human factor VIII and von Willebrand factor in cultured B-cells [J].
Basu, U ;
Banerjee, S .
JOURNAL OF GENE MEDICINE, 2004, 6 (07) :760-768
[3]   A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells [J].
Bernasconi, NL ;
Onai, N ;
Lanzavecchia, A .
BLOOD, 2003, 101 (11) :4500-4504
[4]   Intrinsic immunity: a front-line defense against viral attack [J].
Bieniasz, PD .
NATURE IMMUNOLOGY, 2004, 5 (11) :1109-1115
[5]   The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells [J].
Bourke, E ;
Bosisio, D ;
Golay, J ;
Polentarutti, N ;
Mantovani, A .
BLOOD, 2003, 102 (03) :956-963
[6]   Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors [J].
Bovia, F ;
Salmon, P ;
Matthes, T ;
Kvell, K ;
Nguyen, TH ;
Werner-Favre, C ;
Barnet, M ;
Nagy, M ;
Leuba, F ;
Arrighi, JF ;
Piguet, V ;
Trono, D ;
Zubler, RH .
BLOOD, 2003, 101 (05) :1727-1733
[7]   Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes [J].
Ducrey-Rundquist, O ;
Guyader, M ;
Trono, D .
JOURNAL OF VIROLOGY, 2002, 76 (18) :9103-9111
[8]   Human naive B cells cultured with EL-4 T cells mimic a germinal center-related B cell stage before generating plasma cells. Concordant changes in Bcl-2 protein and messenger RNA levels [J].
Grimaitre, M ;
WernerFavre, C ;
Kindler, V ;
Zubler, RH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (01) :199-205
[9]   Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex [J].
Holler, N ;
Tardivel, A ;
Kovacsovics-Bankowski, M ;
Hertig, S ;
Gaide, O ;
Martinon, F ;
Tinel, A ;
Deperthes, D ;
Calderara, S ;
Schulthess, T ;
Engel, J ;
Schneider, P ;
Tschopp, E .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (04) :1428-1440
[10]   Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent [J].
Janssens, W ;
Chuah, MKL ;
Naldini, L ;
Follenzi, A ;
Collen, D ;
Saint-Remy, JM ;
VandenDriessche, T .
HUMAN GENE THERAPY, 2003, 14 (03) :263-276